Back

Mutual reinforcement of device detected atrial fibrillation and sleep apnea

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation epidemiology (2) Prevalence and Incidence of Atrial Fibrillation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Philipp Spitaler

Medical University of Innsbruck, Innsbruck (Austria)

5 More presentations in this session

Presentation thumbnail
Multimodal deep learning for near term prediction of new onset atrial fibrillation in hospitalized patients
Mr A. Mann (Himachal Pradesh, IN)
Abstract Slides Video
Presentation thumbnail
Predicting atrial fibrillation in the real world: head-to-head comparison of five risk scores
Doctor A. Estrada-Magana (Bronx, US)
Abstract Slides Video
Presentation thumbnail
Rural-urban disparities in atrial fibrillation-related diagnostic testing and medical procedures in Canada
Doctor M. Shurrab (Sudbury, CA)
Abstract Slides Video
Presentation thumbnail
Impact of cardiovascular-kidney-metabolic conditions on clinical outcomes in patients with atrial fibrillation: results from a prospective cohort
Doctor M. Vitolo (Modena, IT)
Abstract Slides Video
Presentation thumbnail
The interplay between total and left atrial pericardial fat and atrial fibrillation: a systematic review and meta-analysis of their associations with AF onset, duration, recurrence, and postoperative
Mr W. Kociemba (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation epidemiology (2)

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Beyond the snore: understanding the impact of sleep apnoea on atrial fibrillation
thumbnail
Congress Presentation
Virtual sleep disordered-breathing management in the work-up of patients with atrial fibrillation: treatment initiation and trajectory within the Virtual-SAFARI study.
thumbnail
Congress Presentation
Change in sleep apnea parameters in patients with atrial fibrillation undergoing pulmonary vein isolation: interim analysis of the AAHIi study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources